Literature DB >> 19908272

Comparison of structure- and ligand-based virtual screening protocols considering hit list complementarity and enrichment factors.

Dennis M Krüger1, Andreas Evers.   

Abstract

Structure- and ligand-based virtual-screening methods (docking, 2D- and 3D-similarity searching) were analysed for their effectiveness in virtual screening against four different targets: angiotensin-converting enzyme (ACE), cyclooxygenase 2 (COX-2), thrombin and human immunodeficiency virus 1 (HIV-1) protease. The relative performance of the tools was compared by examining their ability to recognise known active compounds from a set of actives and nonactives. Furthermore, we investigated whether the application of different virtual-screening methods in parallel provides complementary or redundant hit lists. Docking was performed with GOLD, Glide, FlexX and Surflex. The obtained docking poses were rescored by using nine different scoring functions in addition to the scoring functions implemented as objective functions in the docking algorithms. Ligand-based virtual screening was done with ROCS (3D-similarity searching), Feature Trees and Scitegic Functional Fingerprints (2D-similarity searching). The results show that structure- and ligand-based virtual-screening methods provide comparable enrichments in detecting active compounds. Interestingly, the hit lists that are obtained from different virtual-screening methods are generally highly complementary. These results suggest that a parallel application of different structure- and ligand-based virtual-screening methods increases the chance of identifying more (and more diverse) active compounds from a virtual-screening campaign.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19908272     DOI: 10.1002/cmdc.200900314

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  23 in total

Review 1.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

2.  Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as Highly Active and Selective SGK1 Inhibitors.

Authors:  Nis Halland; Friedemann Schmidt; Tilo Weiss; Joachim Saas; Ziyu Li; Jörg Czech; Matthias Dreyer; Armin Hofmeister; Katharina Mertsch; Uwe Dietz; Carsten Strübing; Marc Nazare
Journal:  ACS Med Chem Lett       Date:  2014-10-23       Impact factor: 4.345

Review 3.  Receptor-ligand molecular docking.

Authors:  Isabella A Guedes; Camila S de Magalhães; Laurent E Dardenne
Journal:  Biophys Rev       Date:  2013-12-21

4.  Conformational ensemble comparison for small molecules in drug discovery.

Authors:  Matthew Habgood
Journal:  J Comput Aided Mol Des       Date:  2018-07-09       Impact factor: 3.686

Review 5.  In silico methods for drug repurposing and pharmacology.

Authors:  Rachel A Hodos; Brian A Kidd; Khader Shameer; Ben P Readhead; Joel T Dudley
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-04-15

6.  Congestion game scheduling for virtual drug screening optimization.

Authors:  Natalia Nikitina; Evgeny Ivashko; Andrei Tchernykh
Journal:  J Comput Aided Mol Des       Date:  2017-12-20       Impact factor: 3.686

7.  Discovery of Mycobacterium tuberculosis α-1,4-glucan branching enzyme (GlgB) inhibitors by structure- and ligand-based virtual screening.

Authors:  Hedwin Kitdorlang Dkhar; Anupriya Gopalsamy; Saurabh Loharch; Amandeep Kaur; Isha Bhutani; Kanmani Saminathan; Ella Bhagyaraj; Vemika Chandra; Kunchithapadam Swaminathan; Pushpa Agrawal; Raman Parkesh; Pawan Gupta
Journal:  J Biol Chem       Date:  2014-11-10       Impact factor: 5.157

8.  Investigating combinatorial approaches in virtual screening on human inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3): a case study for small molecule kinases.

Authors:  Robert B Crochet; Michael C Cavalier; Minsuh Seo; Jeong Do Kim; Young-Sun Yim; Seung-Jong Park; Yong-Hwan Lee
Journal:  Anal Biochem       Date:  2011-07-02       Impact factor: 3.365

9.  Protein flexibility in virtual screening: the BACE-1 case study.

Authors:  Sandro Cosconati; Luciana Marinelli; Francesco Saverio Di Leva; Valeria La Pietra; Angela De Simone; Francesca Mancini; Vincenza Andrisano; Ettore Novellino; David S Goodsell; Arthur J Olson
Journal:  J Chem Inf Model       Date:  2012-10-08       Impact factor: 4.956

Review 10.  Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases.

Authors:  Ahmet Sureyya Rifaioglu; Heval Atas; Maria Jesus Martin; Rengul Cetin-Atalay; Volkan Atalay; Tunca Doğan
Journal:  Brief Bioinform       Date:  2019-09-27       Impact factor: 11.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.